Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budget – Ars Technica
Despite unproven efficacy, Biogen set the drug’s list price at $56,000 per year.
Despite unproven efficacy, Biogen set the drug’s list price at $56,000 per year.
The ASX 200 dropped in early trade as the country braced for further updates on the worsening COVID cloud. Wall Street was mixed…
A young adult is among those who died of COVID-19 in B.C. over the weekend, health officials said in their first update of the…
Queensland’s anxious wait after Premier Annastacia Palaszczuk revealed state ‘on the verge’ of lockdown
A pandemic surge in home buying and renovation sent lumber prices soaring. Now they’re settling down to a new, but elevated level,…
Bitcoin price jumped higher on the opening of the week and broke a crucial descending trend line from May. Regardless, BTC dipped…
Sean Murphy took to Twitter to share how he nearly choked when he was slapped with a £18.27 bill for two pints at a bar in Glasgow…
Rising interest rates will reduce the amount most home buyers can borrow, pushing down house prices in the process, says Greg…
Forced to pay more for wood, home builders want the Biden administration to settle a long-running dispute over Canadian imports….
The economy can wean itself off cheap labour eventually but it will not be a quick or easy process